Waycross Partners’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-187,562	Closed	-$12.4M	–	65
2024 Q3	$12.4M	Buy	187,562 +20,796	+12%	+$1.51M	1.71%	27
2024 Q2	$15.4M	Buy	166,766 +32,296	+24%	+$2.86M	2.36%	15
2024 Q1	$12.8M	Buy	134,470 +11,149	+9%	+$937K	2.21%	21
2023 Q4	$9.4M	Sell	123,321 -7,447	-6%	-$518K	1.76%	26
2023 Q3	$9.06M	Buy	130,768 +6,833	+6%	+$549K	2%	24
2023 Q2	$11.7M	Buy	123,935 +27,144	+28%	+$2.36M	2.54%	14
2023 Q1	$8.01M	Buy	96,791 +17,035	+21%	+$1.34M	2.33%	18
2022 Q4	$5.95M	Buy	+79,756	New	+$6.15M	2.16%	18
2021 Q3	–	Sell	-35,366	Closed	-$3.66M	–	90
2021 Q2	$3.66M	Sell	35,366 -1,785	-5%	-$168K	1.95%	20
2021 Q1	$3.11M	Sell	37,151 -3,659	-9%	-$309K	1.73%	19
2020 Q4	$3.72M	Buy	+40,810	New	+$3.39M	2.36%	15